|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Tetracaine results in increased activity of CASP3 protein |
CTD |
PMID:11981161 |
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO EXP |
HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased expression of CCND1 protein] |
CTD |
PMID:34822839 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression multiple interactions |
ISO |
Tetracaine results in decreased expression of CCNE1 protein HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased expression of CCNE1 protein] |
CTD |
PMID:34822839 |
|
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases phosphorylation multiple interactions |
ISO EXP |
Tetracaine results in decreased phosphorylation of CDK2 protein HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased phosphorylation of CDK2 protein] |
CTD |
PMID:34822839 |
|
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
decreases phosphorylation |
ISO EXP |
Tetracaine results in decreased phosphorylation of CDK4 protein |
CTD |
PMID:34822839 |
|
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
|
|
G |
Cdk6 |
cyclin dependent kinase 6 |
multiple interactions decreases phosphorylation |
ISO |
HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased phosphorylation of CDK6 protein] |
CTD |
PMID:34822839 |
|
NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
|
|
G |
Hnrnpa0 |
heterogeneous nuclear ribonucleoprotein A0 |
increases expression |
ISO EXP |
Tetracaine results in increased expression of HNRNPA0 mRNA |
CTD |
PMID:34822839 |
|
NCBI chr13:58,273,693...58,276,370
Ensembl chr13:58,273,693...58,276,370
|
|
G |
Hnrnpa1 |
heterogeneous nuclear ribonucleoprotein A1 |
decreases response to substance decreases expression multiple interactions |
EXP ISO |
HNRNPA1 protein results in decreased susceptibility to Tetracaine Tetracaine results in decreased expression of HNRNPA1 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetracaine results in decreased expression of HNRNPA1 mRNA]; HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased expression of CCND1 protein]; HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased phosphorylation of CDK2 protein]; Tetracaine results in decreased expression of and results in increased degradation of HNRNPA1 protein benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tetracaine results in decreased expression of HNRNPA1 mRNA]; HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased expression of CCND1 protein]; HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased expression of CCNE1 protein]; HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased phosphorylation of CDK2 protein]; HNRNPA1 protein inhibits the reaction [Tetracaine results in decreased phosphorylation of CDK6 protein]; Tetracaine results in decreased expression of and results in increased degradation of HNRNPA1 protein |
CTD |
PMID:34822839 |
|
NCBI chr15:103,148,840...103,155,119
Ensembl chr15:103,148,859...103,155,119
|
|
G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
decreases expression |
EXP |
Tetracaine results in decreased expression of HNRNPA2B1 mRNA |
CTD |
PMID:34822839 |
|
NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874
|
|
G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C |
increases expression decreases expression |
ISO EXP |
Tetracaine results in increased expression of HNRNPC mRNA Tetracaine results in decreased expression of HNRNPC mRNA |
CTD |
PMID:34822839 |
|
NCBI chr14:52,310,834...52,341,462
Ensembl chr14:52,310,834...52,341,485
|
|
G |
Hrh1 |
histamine receptor H1 |
multiple interactions affects binding |
ISO |
[HRH1 protein binds to Tetracaine] which results in increased import of Calcium |
CTD |
PMID:32061592 |
|
NCBI chr 6:114,374,897...114,459,432
Ensembl chr 6:114,374,897...114,460,257
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK1 protein]; Curcumin inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK1 protein]; Egtazic Acid promotes the reaction [Tetracaine results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11981161 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK3 protein]; Curcumin inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK3 protein]; Egtazic Acid promotes the reaction [Tetracaine results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11981161 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions increases phosphorylation |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK8 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Tetracaine results in increased phosphorylation of MAPK8 protein]; Curcumin inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK8 protein]; Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:11981161 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions increases phosphorylation |
ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein]; Curcumin inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein]; Egtazic Acid inhibits the reaction [Tetracaine results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:11981161 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases activity decreases expression |
ISO |
Tetracaine results in decreased activity of MMP2 protein Tetracaine results in decreased expression of MMP2 mRNA |
CTD |
PMID:37806380 |
|
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases activity decreases expression |
ISO |
Tetracaine results in decreased activity of MMP9 protein Tetracaine results in decreased expression of MMP9 mRNA |
CTD |
PMID:37806380 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Ryr1 |
ryanodine receptor 1, skeletal muscle |
multiple interactions |
EXP |
Tetracaine inhibits the reaction [tetrabromobisphenol A results in increased activity of RYR1 protein] |
CTD |
PMID:18329244 |
|
NCBI chr 7:28,702,765...28,824,599
Ensembl chr 7:28,702,769...28,824,604
|
|
G |
Scn10a |
sodium channel, voltage-gated, type X, alpha |
multiple interactions |
ISO |
Tetracaine inhibits the reaction [decamethrin results in increased activity of SCN10A protein] |
CTD |
PMID:16325806 |
|
NCBI chr 9:119,437,522...119,548,388
Ensembl chr 9:119,437,522...119,548,388
|
|
G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
multiple interactions |
ISO |
Tetracaine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] |
CTD |
PMID:21599003 |
|
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
|
|
G |
Timp2 |
tissue inhibitor of metalloproteinase 2 |
increases expression |
ISO |
Tetracaine results in increased expression of TIMP2 mRNA |
CTD |
PMID:37806380 |
|
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
increases activity multiple interactions |
ISO |
Tetracaine results in increased activity of TRPV1 protein Tetracaine promotes the reaction [Capsaicin results in increased activity of TRPV1 protein] |
CTD |
PMID:15854744 PMID:18172555 |
|
NCBI chr11:73,124,975...73,152,148
Ensembl chr11:73,125,118...73,152,068
|
|